James Fund for Life

In 2002, Abigail and Les Wexner launched The James Fund for Life — the first annual fund campaign supporting leading-edge research, clinical trials and technology at the OSUCCC – James.

Past James Fund for Life Acquisitions

2009 – 2014

Funding for technology in the new James Cancer Hospital and Solove Research Institute.

2008 Flow Cytometer

This sophisticated instrument enables medical scientists to rapidly measure physical and chemical properties of cells and particles. Flow cytometers, which consist of electrical, digital and optical components, allow for accurate analysis of DNA, cell cycle, cell function and cell death. This analysis is of paramount importance in helping scientists understand the basic properties of cancer in its many forms — insight that translates to innovative treatment at the OSUCCC – James. In 2008, a new Technology Acquisition Fund was created to support the attainment of equipment for the new James Cancer Hospital and Solove Research Institute.

2007 Digital Mobile Mammography Unit & Funds for Technology Needs of the New Survivorship Center

The addition of this new, high-tech mobile unit with digital mammogram capabilities to the JamesCare comprehensive breast program greatly enhances our ability to identify and treat breast cancer in the Columbus region and provides the opportunity to reach areas of Ohio that do not have easy access to mammography. This increases the number of mammogram-detected breast cancers and provides patients with the ability to participate in clinical trials. It also allows OSUCCC – James doctors to look at different biomarkers that increase knowledge and have an impact on treatment options. In addition to the mobile unit, proceeds also supported the technology needs of the survivorship center.

2006 Robotic Surgical Equipment — daVinci Robot

The OSUCCC – James has become a leader in robotic surgery, impacting surgeons and patients around the world. The first robot was in high demand, and the 2006 gift allowed the OSUCCC – James to add a second robot to its surgical lineup, giving patients and doctors more access to the latest surgical technology. It not only allows us to provide minimally invasive treatment for multiple cancers, but also positions the OSUCCC – James to expand the use of surgical robots to treat a variety of noncancerous conditions at The Ohio State University’s Center for Robotics and Computer-Assisted Surgery.

2005 Stereotactic Radiosurgery & Image-Guided Radiation Therapy

This technology provides nonsurgical treatment to tumor sites outside the brain with pinpoint accuracy to reduce damage to healthy tissue. The equipment complements the Division of Radiation Oncology’s existing stereotactic radiosurgery program, which currently treats only brain tumors.

2004 Robotic Surgical Equipment & Technology

With the acquisition of this technology, the OSUCCC – James successfully recruited world-class experts to its robotics and minimally invasive urological surgery program. Surgeons have been able to perform procedures with greater precision and dexterity, allowing patients to recover more quickly, with minimal pain and an earlier return to normal activity.

2003 Intra-Operative MRI System

The physicians of the neurological surgery department are able to better diagnose and treat certain types of cancer with this intra-operative technology unlike any other in central Ohio. This system provides a valuable adjunct to standard neurological care, allowing the surgeon full access to the patient and providing state-of-the-art imaging during surgery.

2002 PET/CT Scanner

The acquisition of a Siemens PET/CT scanner combined the imaging technologies of positron emission tomography (PET) and computer tomography (CT) to offer the ultimate imaging performance for improved diagnosis and treatment in oncology, neurology and cardiology.

Give By Mail

The OSUCCC – James
660 Ackerman Road, 6th Floor
PO Box 183112
Columbus, OH 43218-3112

Contact Us

OSUCCC – James Development Office

Phone

614-293-3752

Email

annualgiving@osumc.edu

By Mail

660 Ackerman Road, 6th Floor
PO Box 183112
Columbus, OH 43218-3112

Latest News

Prostate Cancer Androgen Receptor Activates a Different Gene Set When Bound to Antiandrogens

The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new study led by...

Read More

Individualizing Treatments for Multiple Myeloma

This week on Toward a Cancer-Free World, Dr. Craig Hofmeister shares how using an actual virus to help treat certain blood cancer patients may just get us even closer to a cancer-free world.

Read More

Generating New Hope Through Pelotonia-Funded Research

Pelotonia funds support cancer drug development projects at Ohio State. Here’s a brief look at a basic-science study of a targeted agent that may improve cancer-killing virus therapy, and two clinical...

Read More